Insights into Full-congener Profiles of Chlorinated Benzenes in Fly and Bottom Ash: Case Study in Vietnamese Industrial and Municipal Waste Incinerators.

Chlorinated benzenes (CBzs) are a group of organic pollutants, which have been industrially or unintentionally produced through various chemical and thermal processes. Studies on full congener profiles of CBzs in waste and environmental samples are relatively limited and not updated. In the present study, concentrations of 12 CBzs were determined in fly ash (FA) and bottom ash (BA) samples collected from one municipal waste incinerator (MWI) and one industrial waste incinerator (IWI) in northern Vietnam. Levels of Σ12CBzs were higher in bottom ash (median 25.3; range 1.59-45.7 ng/g) than in fly ash (median 7.30; range 1.04-30.0 ng/g). The CBz profiles were dominated by di- and tri-chlorinated congeners with the major congeners as 1,2,4-TCB, 1,2,3-TCB, 1,2-DCB, and 1,3-DCB. However, CBz profiles varied greatly between sample types and incinerators, implying differences in input materials, formation pathways, and pollutant behaviors. Incomplete combustion is possibly responsible for high levels of CBzs in industrial bottom ash. The emission factors of Σ12CBzs ranged from 21 to 600 µg/ton for fly ash and from 190 to 4570 µg/ton for bottom ash, resulting in annual emissions of about 6 and 3 g/year for the IWI and MWI, respectively. Our results suggest additional investigations on industrial emission and environmental occurrence of all 12 CBzs rather than solely focusing on regulated congeners like hexachlorobenzene and pentachlorobenzene.

Low-Dose vs. Standard-Dose Intravenous Alteplase in Bridging Therapy Among Patients With Acute Ischemic Stroke: Experience From a Stroke Center in Vietnam.

Background: To date, the role of bridging intravenous thrombolysis before mechanical thrombectomy (MTE) is controversial but still recommended in eligible patients. Different doses of intravenous alteplase have been used for treating patients with acute ischemic stroke from large-vessel occlusion (LVO-AIS) in Asia, largely due to variations in the risks for intracerebral hemorrhage (ICH) and treatment affordability. Uncertainty exists over the potential benefits of treating low-dose alteplase, as opposed to standard-dose alteplase, prior to MTE among patients with LVO-AIS. Aim: The aim of the study was to compare outcomes of low- vs. standard-dose of bridging intravenous alteplase before MTE among LVO-AIS patients. Methods: We performed a retrospective analysis of LVO-AIS patients who were treated with either 0.6 mg/kg or 0.9 mg/kg alteplase prior to MTE at a stroke center in Northern Vietnam. Multivariable logistic regression models, accounting for potential confounding factors including comorbidities and clinical factors (e.g., stroke severity), were used to compare the outcomes between the two groups. Our primary outcome was functional independence at 90 days following stroke (modified Rankin score; mRS ≤ 2). Secondary outcomes included any ICH incidence, early neurological improvement, recanalization rate, and 90-day mortality. Results: We analyzed data of 107 patients receiving bridging therapy, including 73 with low-dose and 34 with standard-dose alteplase before MTE. There were no statistically significant differences between the two groups in functional independence at 90 days (adjusted OR 1.02, 95% CI 0.29-3.52) after accounting for potential confounding factors. Compared to the standard-dose group, patients with low-dose alteplase before MTE had similar rates of successful recanalization, early neurological improvement, 90-day mortality, and ICH complications. Conclusion: In the present study, patients with low-dose alteplase before MTE were found to achieve comparable clinical outcomes compared to those receiving standard-dose alteplase bridging with MTE. The findings suggest potential benefits of low-dose alteplase in bridging therapy for Asian populations, but this needs to be confirmed by further clinical trials.

Co-Doped NdFeO3 Nanoparticles: Synthesis, Optical, and Magnetic Properties Study.

In this work, single-phase nanostructured NdFe1-xCoxO3 (x = 0, 0.1, 0.2, and 0.3) perovskite materials were obtained by annealing stoichiochemistry mixtures of their component hydroxides at 750 °C for 60 min. The partial substitution of Fe by Co in the NdFeO3 crystal lattice leads to significant changes in the structural characteristics, and as a consequence, also alters both the magnetic and optical properties of the resulting perovskites. The low optical band gap (Eg = 2.06 ÷ 1.46 eV) and high coercivity (Hc = 136.76 ÷ 416.06 Oe) give Co-doped NdFeO3 nanoparticles a huge advantage for application in both photocatalysis and hard magnetic devices.

Concentrations, profiles, emission inventory, and risk assessment of chlorinated benzenes in bottom ash and fly ash of municipal and medical waste incinerators in northern Vietnam.

Concentrations and congener profiles of seven di- to hexachlorinated benzenes (CBzs) were characterized in bottom ash and fly ash samples collected simultaneously from one medical waste incinerator (MEWI) and one municipal waste incinerator (MUWI) in northern Vietnam. Total concentrations of seven CBzs in the fly ash samples ranged from 6.98 to 34.4 (median 19.1) ng g-1 in the MEWI, and ranged from 59.1 to 391 (median 197) ng g-1 in the MUWI. Concentrations of CBzs in the bottom ash samples of the MEWI (median 1.95; range 1.53-5.98 ng g-1) were also lower than those measured in the MUWI samples (median 17.4; range 14.5-42.6 ng g-1). Levels of CBzs in the fly ash samples were significantly higher than concentrations measured in the bottom ash samples, partially indicating the low-temperature catalytic formation of these pollutants in post-combustion zone. In general, higher chlorinated congeners (e.g., hexachlorobenzene, pentachlorobenzene, and 1,2,4,5-tetrachlorobenzene) were more abundant than lower chlorinated compounds. However, compositional profiles of CBzs were different between the ash types and incinerators and even between the same sample types of different sampling days, suggesting that the formation of CBzs in these incinerators is complicated and influenced by many factors. Emission factors and annual emission amounts of CBzs were estimated for the two incinerators by using actually measured data of CBz concentrations in the ash. Daily intake doses and cancer risks of ash-bound CBzs estimated for workers in the two incinerators were generally lower than critical values, but cancer risks caused by other relevant pollutants (e.g., polycyclic aromatic hydrocarbons, polychlorinated biphenyls, and dioxin-related compounds) were not considered.

Improving CRISPR-Cas specificity with chemical modifications in single-guide RNAs.

CRISPR systems have emerged as transformative tools for altering genomes in living cells with unprecedented ease, inspiring keen interest in increasing their specificity for perfectly matched targets. We have developed a novel approach for improving specificity by incorporating chemical modifications in guide RNAs (gRNAs) at specific sites in their DNA recognition sequence ('guide sequence') and systematically evaluating their on-target and off-target activities in biochemical DNA cleavage assays and cell-based assays. Our results show that a chemical modification (2'-O-methyl-3'-phosphonoacetate, or 'MP') incorporated at select sites in the ribose-phosphate backbone of gRNAs can dramatically reduce off-target cleavage activities while maintaining high on-target performance, as demonstrated in clinically relevant genes. These findings reveal a unique method for enhancing specificity by chemically modifying the guide sequence in gRNAs. Our approach introduces a versatile tool for augmenting the performance of CRISPR systems for research, industrial and therapeutic applications.